The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Laboratory Corporation of America Holdings

NYSE: LH
Last

(U.S.) $127.95

Today's change0.00 0.00%
Updated May 31 4:06 PM EDT. Delayed by at least 15 minutes.
 

Laboratory Corporation of America Holdings

NYSE: LH
Last

(U.S.) $127.95

Today's change0.00 0.00%
Updated May 31 4:06 PM EDT. Delayed by at least 15 minutes.

Laboratory Corporation of America Holdings closed at (U.S.)$127.95.

Over the last five days, shares are unchanged, but are currently 1.04% below its 52-week high. This security has outperformed the S&P 500 by 8.97% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $127.95
  • High--
  • Low--
  • Bid / Ask-- / --
  • YTD % change+3.49%
  • Volume0
  • Average volume (10-day)673,850
  • Average volume (1-month)941,521
  • Average volume (3-month)951,273
  • 52-week range(U.S.) $97.79 to (U.S.) $129.29
  • Beta0.89
  • Trailing P/E22.12×
  • P/E 1 year forward14.55×
  • Forward PEG1.43×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $5.78
Updated May 31 4:06 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+6.45%

Based on its net profit margin of 6.45%, Laboratory Corporation of America Holdings is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.15%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015
Revenue2,3682,3012,3172,269
Total other revenue--------
Total revenue2,3682,3012,3172,269
Gross profit777741763775
Total cost of revenue1,5911,5601,5541,495
Total operating expense2,0662,0572,0101,948
Selling / general / administrative412405383392
Research & development--------
Depreciation / amortization44384747
Interest expense (income), net operating--------
Unusual expense (income)19542614
Other operating expenses, total--------
Operating income302243307321
Interest income (expense), net non-operating-55-57-56-58
Gain (loss) on sale of assets--------
Other--------
Income before tax256186250264
Income after tax161115153169
Income tax, total96729796
Net income160114153168
Total adjustments to net income--------
Net income before extra. items160114153168
Minority interest0000
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items160114153168
Inc. avail. to common incl. extra. items160114153168
Diluted net income161114153168
Dilution adjustment0--00
Diluted weighted average shares104103103103
Diluted EPS excluding extraordinary itemsvalue per share1.551.111.481.64
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share1.671.431.641.73
R